肝细胞癌患者血清中EGFRvIII信使核糖核酸的检测 - Suppr

Suppr

超能文献

EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinoma.

作者信息

Zhou Min, Gong Bangdong, Gu Jianren, Li Zonghai

出版信息

Liver Int. 2010 Jul;30(6):925-7. doi: 10.1111/j.1478-3231.2010.02233.x. Epub 2010 Apr 8.

DOI:10.1111/j.1478-3231.2010.02233.x

PMID:20408943

Abstract

摘要

相似文献

EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinoma.

Liver Int. 2010 Jul;30(6):925-7. doi: 10.1111/j.1478-3231.2010.02233.x. Epub 2010 Apr 8.

Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.

Hepatology. 1997 Apr;25(4):896-9. doi: 10.1002/hep.510250418.

Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.

Mol Carcinog. 2003 Mar;36(3):130-41. doi: 10.1002/mc.10103.

Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.

Clin Cancer Res. 2005 May 1;11(9):3205-9. doi: 10.1158/1078-0432.CCR-04-1487.

Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.

Cancer Res. 1997 Nov 15;57(22):5179-84.

Epidermal growth factor receptor mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure.

Clin Cancer Res. 2001 Dec;7(12):4288-9.

Detection of albumin messenger RNA in blood is not restricted to hepatocellular carcinoma.

Hepatology. 1996 Jun;23(6):1708-9. doi: 10.1002/hep.510230660.

Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.

Cancer Lett. 2009 Jun 28;279(1):30-8. doi: 10.1016/j.canlet.2009.01.019. Epub 2009 Feb 12.

The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.

J Exp Clin Cancer Res. 2005 Sep;24(3):415-21.

Hepatocellular carcinoma: susceptibility markers.

IARC Sci Publ. 2001;154:241-4.

引用本文的文献

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.

Oncotarget. 2017 Jan 24;8(4):6364-6375. doi: 10.18632/oncotarget.14088.

EGFR Signaling in Liver Diseases.

Int J Mol Sci. 2015 Dec 29;17(1):30. doi: 10.3390/ijms17010030.

EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.

PLoS One. 2013 Dec 20;8(12):e83332. doi: 10.1371/journal.pone.0083332. eCollection 2013.

The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.

J Gastroenterol. 2014 Jan;49(1):9-23. doi: 10.1007/s00535-013-0907-x. Epub 2013 Dec 10.

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.

Cancers (Basel). 2011 May 18;3(2):2444-61. doi: 10.3390/cancers3022444.

The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.

Neoplasia. 2012 Jun;14(6):509-18. doi: 10.1593/neo.12328.

Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.

J Biol Chem. 2011 Feb 18;286(7):5913-20. doi: 10.1074/jbc.M110.192252. Epub 2010 Dec 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验